Feedback

Dexamethasone reduces mortality from Covid-19 by one third, - British scientists

Source : 112 Ukraine

WHO welcomed initial clinical trial results
20:56, 17 June 2020

Open source

The World Health Organization welcomed the initial results of clinical trials of dexamethasone, which, as scientists have found, reduces mortality from coronavirus by a third. The press service of WHO reports.

The first trials of the drug showed that dexamethasone could save the lives of the critically ill patients.

Related: External independent testing not to be cancelled in 2020, - Ukraine’s PM

"For patients on ventilators, the treatment was shown to reduce mortality by about one third, and for patients requiring only oxygen, mortality was cut by about one fifth, according to preliminary findings shared with WHO," the WHO said.

It is noted that the advantage of the drug was observed only in patients who are seriously ill with Covid-19.

According to WHO Director-General Tedros Ghebreyesus, this is the first drug that reduces mortality in patients with coronavirus infection.

"This is great news, and I congratulate the UK government, Oxford University, and many hospitals and patients in the UK who have contributed to this salutary scientific breakthrough," he said.

Related: Ukraine's PM instructed Ministry of Finance to audit costs from ‘coronavirus fund’

Dexamethasone has been reported to be a steroid that has been used since the 1960s to reduce inflammation in a number of conditions, including inflammatory diseases and certain types of cancer.

As we reported before, Health Minister Maksym Stepanov stated that Ukraine has started the talks with the number of the countries on the pre-order of the vaccine against coronavirus infection

Topics:
Система Orphus

If you find an error, highlight the desired text and press Ctrl + Enter, to tell about it

Comments
see more